SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Review discusses what is currently known about human humoral and cellular immune responses to severe acute respiratory syndrome coronavirus 2 and relates this knowledge to the COVID-19 vaccines currently in phase 3 clinical trials.

The Lancet